These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30967432)

  • 41. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.
    Kemppainen KM; Vehik K; Lynch KF; Larsson HE; Canepa RJ; Simell V; Koletzko S; Liu E; Simell OG; Toppari J; Ziegler AG; Rewers MJ; Lernmark Å; Hagopian WA; She JX; Akolkar B; Schatz DA; Atkinson MA; Blaser MJ; Krischer JP; Hyöty H; Agardh D; Triplett EW;
    JAMA Pediatr; 2017 Dec; 171(12):1217-1225. PubMed ID: 29052687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.
    Steck AK; Johnson K; Barriga KJ; Miao D; Yu L; Hutton JC; Eisenbarth GS; Rewers MJ
    Diabetes Care; 2011 Jun; 34(6):1397-9. PubMed ID: 21562325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years.
    Webb-Robertson BM; Nakayasu ES; Frohnert BI; Bramer LM; Akers SM; Norris JM; Vehik K; Ziegler AG; Metz TO; Rich SS; Rewers MJ
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2329-2338. PubMed ID: 35468213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study.
    Silvis K; Aronsson CA; Liu X; Uusitalo U; Yang J; Tamura R; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler A; Akolkar B; Krischer J; Virtanen SM; Norris JM;
    Pediatr Diabetes; 2019 Feb; 20(1):86-92. PubMed ID: 30411443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
    Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
    J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers.
    Webb-Robertson BM; Bramer LM; Stanfill BA; Reehl SM; Nakayasu ES; Metz TO; Frohnert BI; Norris JM; Johnson RK; Rich SS; Rewers MJ
    J Diabetes; 2021 Feb; 13(2):143-153. PubMed ID: 33124145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
    Maziarz M; Janer M; Roach JC; Hagopian W; Palmer JP; Deutsch K; Sanjeevi CB; Kockum I; Breslow N; Lernmark A; ;
    Genes Immun; 2010 Jul; 11(5):406-15. PubMed ID: 20445565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. rs11203203 is associated with type 1 diabetes risk in population pre-screened for high-risk HLA-DR,DQ genotypes.
    Johnson K; Wong R; Barriga KJ; Klingensmith G; Ziegler AG; Rewers MJ; Steck AK
    Pediatr Diabetes; 2012 Dec; 13(8):611-5. PubMed ID: 22776074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Timing of initial cereal exposure in infancy and risk of islet autoimmunity.
    Norris JM; Barriga K; Klingensmith G; Hoffman M; Eisenbarth GS; Erlich HA; Rewers M
    JAMA; 2003 Oct; 290(13):1713-20. PubMed ID: 14519705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.
    Velluzzi F; Secci G; Sepe V; Klersy C; Shattock M; Foxon R; Songini M; Mariotti S; Locatelli M; Bottazzo GF; Loviselli A;
    Acta Diabetol; 2016 Feb; 53(1):73-9. PubMed ID: 25896008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Infant Diet and Islet Autoimmunity in the TEDDY Study.
    Uusitalo U; Lee HS; Andrén Aronsson C; Vehik K; Yang J; Hummel S; Silvis K; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler AG; Akolkar B; Krischer J; Virtanen SM; Norris JM;
    Diabetes Care; 2018 Mar; 41(3):522-530. PubMed ID: 29343517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children.
    Bonifacio E; Beyerlein A; Hippich M; Winkler C; Vehik K; Weedon MN; Laimighofer M; Hattersley AT; Krumsiek J; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Oram RA; Rich SS; Ziegler AG;
    PLoS Med; 2018 Apr; 15(4):e1002548. PubMed ID: 29614081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY).
    Frederiksen BN; Kroehl M; Fingerlin TE; Wong R; Steck AK; Rewers M; Norris JM
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1845-51. PubMed ID: 23979957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.